|
Transitioning to healthy diets from sustainable food systems in Belgium: Priority policy actions and their multiple sustainability impacts |
SUSFOODBEL |
September 1, 2022 |
December 31, 2026 |
Health information |
healthy diets, sustainable food systems, policy priorities, impact assessment |
|
Improved monitoring of the disease burden attributable to substance use |
SUBOD |
December 15, 2022 |
March 15, 2025 |
Health information |
Disability-Adjusted Life Years, attributable burden, economic costs, mortality, prevention, tobacco, alcohol |
|
Research into the dietary exposure of the Belgian Population to Steviol Glycosides |
Stevia |
August 1, 2019 |
January 31, 2021 |
Organic contaminants and additives |
sweeteners, steviol glycosides, dietary intake |
|
Development and implementation of a Belgian platform for the generation and use of “whole genome sequencing” (WGS) data for outbreak investigation, with the for human pathogenic Shiga-toxin producing Escherichia coli (STEC) as case study |
StEQIDEMIC.be |
May 1, 2018 |
December 31, 2021 |
Foodborne pathogens, Transversal activities in applied genomics |
NGS, outbreak, food safety, whole genome sequencing, NRL, NRC, STEC, human pathogenic Shiga-toxin producing Escherichia coli, applied genomics, food-borne outbreak, pathogen, isolate, metagenomics, norovirus |
|
Analysis of the prevalence, genetic variation and cross-species transmission of lentiviruses of small ruminants (SRLV: Maedi-Visna, CAEV) in Belgium with a view to optimising the diagnosis and support of the policy on voluntary SRL |
SRLV-BEL |
August 1, 2015 |
August 31, 2018 |
Viral reemerging enzootic and bee diseases |
lentiviruses of small ruminants, Maedi-Visna virus, caprine arthritis and encefalitis virus, seroprevalence, diagnosis, genetic variation, intra-species transmission, cross-species transmission |
|
Standardized Procedures of Mortality Analysis |
SPMA |
January 1, 2002 |
|
Health information |
Overall mortality, Cause specific mortality, Perinatality, Midyear population, Births, Infant mortality |
|
Measuring Social Participation Among People Living With Chronic Diseases |
SPADIS |
January 1, 2022 |
December 31, 2026 |
Cancer centre |
epidemiology, chronic diseases, social participation, Patient reported outcome measures (PROMs), Patient reported experience measures (PREMs) |
|
Applicability of in silico tools to support the risk assessment of non-evaluated substances migrating from food contact materials RF 21/6349 |
SILIFOOD |
October 1, 2021 |
March 31, 2023 |
|
risk assessment, food contact materials, in silico tools, (Q)SAR models, endocrine disruption, VEGA |
|
Nuclear Emergency Situations Improvement of Medical and Health Surveillance |
SHAMISEN |
December 1, 2015 |
May 31, 2017 |
Risk and health impact assessment |
nuclear accident, recommendations, medical and health surveillance, populations affected |
|
Network of General Practitioners |
SGPs |
January 1, 1979 |
|
Health services research, Epidemiology of infectious diseases |
surveillance, sentinel, general practice |
|
Prevalence and Incidence of antibodies against SARS-CoV-2 in children and school staff for one year in Belgium: A seroepidemiological prospective cohort study |
SeroCoBelChild |
October 1, 2020 |
March 31, 2022 |
Healthcare-associated infections and antimicrobial resistance |
SARS-CoV-2, antibodies, seroprevalence, school environment, children, school staff, Belgium |
|
Sequencing of SARS-CoV-2 viruses detected in the context of ILI, SARI and other COVID-19 laboratory surveillance and surveillance studies |
SEQ-COVID-19-LABSURV |
March 1, 2021 |
December 31, 2023 |
|
SARS-CoV-2, genomic surveillance, SARI surveillance, NGS, NRC, respiratory infection, coronavirus |
|
Understanding the dynamics and consequences of new psychoactive substances use in a rapidly changing (online) drug market |
SCANNER |
October 1, 2020 |
November 30, 2022 |
Health information |
NPS, new psychoactive substances, illicit drugs, drug use, influence legislation, ringtesting, proficiency testing, helplines and drug checking services, civil society organisations, fentanyl hotspots |
|
SARS-CoV-2 prevalence, seroprevalence and seroconversion among healthcare workers in Belgium during the COVID-19 outbreak between April 2020 and April 2021 |
SARS-CoV-2 HCW |
March 1, 2020 |
July 31, 2021 |
Healthcare-associated infections and antimicrobial resistance |
COVID-19, SARS-CoV-2, seroprevalence, healthcare worker, infection control, public health |
|
Surveillance of antimicrobial resistance in primary care - focus on uncomplicated uninary tract infections |
SARPRIC-UTI |
January 1, 2023 |
December 31, 2024 |
Healthcare-associated infections and antimicrobial resistance |
surveillance, antimicrobial resistance, AMR, primary health care, general medicine |
|
Severe Acute Respiratory Infection surveillance by a sentinel network of hospitals |
SARI |
January 1, 2012 |
|
Viral diseases, Epidemiology of infectious diseases |
SARI surveillance, severe acute respiratory infections, sentinel, Influenza |
|
More rapid and accurate identification of (zoonotic) Salmonella serotypes that are the object of official control in poultry and pork |
SALMSTID |
November 1, 2015 |
August 31, 2018 |
Bacterial diseases, Transversal activities in applied genomics |
salmonella, genetic serotyping, Luminex, Multiplex |
|
Salmonella biofilm formation in chronic carrier pigs: impact on gut colonization & antibiotic tolerance; functional diagnostics; and potential as target for non-antibiotic therapy |
SalmiPIG |
July 1, 2021 |
June 30, 2025 |
Transversal activities in applied genomics |
biofilm, salmonella, genetic marker, pig, pork, whole genome sequencing, bioinformatics, variant analysis |
|
Study on the prevalence of antibodies against the coronavirus (SARS-CoV-2) in the Belgian population |
SalivaHIS |
January 1, 2021 |
June 30, 2022 |
Viral diseases, Immune response, Laboratory of medical microbiology (LMM), Health information, Epidemiology of infectious diseases |
|
|
Risk-based Screening for Cervical Cancer (RISCC) |
RISCC |
January 1, 2020 |
December 21, 2024 |
Cancer centre |
screen programme, risk assessment, numerical analysis, simulation, optimisation, modelling tools, cervical cancer screening, risk stratification, predictive modelling, health-economic modelling, digital applications |
|
Assessing spatio-temporal relationships between respiratory health and biodiversity using individual wearable technology |
RespirIT |
December 15, 2015 |
September 15, 2020 |
Mycology and aerobiology , Risk and health impact assessment |
allergy, pollen, mobile health, ecohealth, rhinitis, respiratory health, GPS tracking, citizen science, biodiversity |
|
Development and application of differential diagnosis for respiratory viruses to improve surveillance and understanding of acute respiratory infectious disease in Belgium |
Respi |
October 1, 2015 |
December 31, 2019 |
Epidemiology and public health, Viral diseases |
influenza virus, respiratory viruses, severity, co-infection |
|
Responding to outbreaks through co-creative inclusive equality strategies and collaboration |
RESISTIRÉ |
April 1, 2021 |
September 30, 2023 |
|
COVID-19, gender, social inequalities, Europe |
|
Release of nano-objects, their aggregates and agglomerates from protective face masks |
Renaame |
January 1, 2023 |
March 25, 2026 |
Trace elements and nanomaterials |
|
|
Reference materials as metrological tools for emerging and regulated mycotoxins and for animal experiments |
RefMat |
January 2, 2010 |
|
|
Matrix reference materials, safety, mycotoxins, food, feed, metrology, quality control, interlaboratory comparison, carry-over, mitigation, metabolite profiling, metrofood |
|
Context-Specific Interventions for Nutrition-Related Non-Communicable Diseases Prevention in East Africa |
RECAP |
April 1, 2020 |
March 31, 2023 |
Health information |
non-communicable diseases, low-middle income countries, food environments, nutrition policy, food marketing |
|
Exploring the person-centredness of the Investigation to reveal the immune reaction upon COVID-vaccination in the Belgian cancer population: COVID protection and Vaccine safety study |
REAL-V |
January 1, 2022 |
March 31, 2023 |
Cancer centre |
patient-centered-care, life change event, clinical trials |
|
An online tool to collect New Approach Methodologies (NAMs) in one central database |
RE-Place |
April 18, 2017 |
April 30, 2024 |
Risk and health impact assessment |
3R, replacement, alternative methods, in vitro, in silico, in chemico, new technologies |
|
Lumpy skin disease in Belgian cattle and potential vectors: risk assessment, diagnosis, control, vaccination, transmission and vector competence studies to prevent the introduction and spread |
RCO LUMPY SKIN |
January 1, 2016 |
December 31, 2018 |
Viral reemerging enzootic and bee diseases, Exotic and vector-borne diseases |
lumpy skin disease, risk assessment, diagnosis, control, vaccination, transmission, vector competence |
|
Coordination of the Risk Assessment Group |
RAG |
January 1, 2007 |
|
Foodborne pathogens, Viral diseases, Avian virology and immunology, Crisis Coordination |
risk analysis, crisis management |
